-
-
-
-
-
-
-
enVVeno Medical Reports Second Quarter 2026 Financial Results and Advances Towards FDA Pivotal Trial for First-in-Class Non-Surgical Replacement Venous Valve
-
-
-
-
-
-
-
enVVeno Medical Discusses FDA IDE Approval in Virtual Investor "What This Means" Segment
-
-
-
-
-
-
-
enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
-
-
-
-
-
-
enVVeno Medical Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
enVVeno Medical (NVNO) Halted, News Pending
-
-
-
-
-
-
-
JTC Team Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference Now Live
-
-
-
-
-
-
-
enVVeno Medical to Participate in a Live Virtual Investor Closing Bell Segment
-
461,083 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

